Patent Yard Sign in
Canadian application, no grantCanada

Substituted derivatives of piperizinylcamphorsulfonyl oxytocin antagonists

CA 2078264 A1 · Owner: Bock, Mark G. · Inventors: Williams, Peter D.; Bock, Mark G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of the formula: 81/FPG45, - i - 18449, wherein R is oxime hydroxy, halolgen, cyclic epoxide, alkylcarbonyloxy alkoxycarbonylalkoxy, trihalo-, alkylsulfonyloxo or unsubstituted or substituted oxo, where said substituent is unsubstituted or substituted saturated 6-membered heterocyclic rings having 1 or 2 heteroatoms which are N, and said substituent is alkyl. The compounds of formula I are oxytocin antagonists useful in the treatment of preterm labor dysmenorrhea and for the stoppage of labor preparatory to cesarean delivery. Also disclosed are pharmaceutical compositions containing these compounds methods, of their use and methods of their preparation.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 15, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 15, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 15, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 15, 1992
GrantedNo grant recorded
Term endedSeptember 15, 2012
Patent numberCA 2078264 A1
Classification (IPC)C07D295/26 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedSep 15, 1992Term endedSep 15, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.